178 related articles for article (PubMed ID: 36695975)
1. Survival after resection of brain metastasis: impact of synchronous versus metachronous metastatic disease.
Potthoff AL; Heimann M; Lehmann F; Ilic I; Paech D; Borger V; Radbruch A; Schäfer N; Schuss P; Vatter H; Herrlinger U; Schneider M
J Neurooncol; 2023 Feb; 161(3):539-545. PubMed ID: 36695975
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Factors for Survival of Patients With Synchronous or Metachronous Brain Metastasis of Renal Cell Carcinoma.
Choi SY; Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
Clin Genitourin Cancer; 2017 Dec; 15(6):717-723. PubMed ID: 28552571
[TBL] [Abstract][Full Text] [Related]
3. Synchronous versus metachronous spinal metastasis: a comparative study of survival outcomes following neurosurgical treatment.
Banat M; Potthoff AL; Hamed M; Borger V; Scorzin JE; Lampmann T; Asoglu H; Khalafov L; Schmeel FC; Paech D; Radbruch A; Nitsch L; Weller J; Herrlinger U; Toma M; Gielen GH; Vatter H; Schneider M
J Cancer Res Clin Oncol; 2024 Mar; 150(3):136. PubMed ID: 38502313
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer.
Fleckenstein J; Petroff A; Schäfers HJ; Wehler T; Schöpe J; Rübe C
BMC Cancer; 2016 Jun; 16():348. PubMed ID: 27255302
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and survival outcomes of synchronous and metachronous brain metastases: a retrospective population-based study.
Jiang K; Parker M; Materi J; Azad TD; Kamson DO; Kleinberg L; Ye X; Rincon-Torroella J; Bettegowda C
Neurosurg Focus; 2023 Aug; 55(2):E3. PubMed ID: 37527669
[TBL] [Abstract][Full Text] [Related]
6. Impact of Systemic Therapy in Metastatic Renal-Cell Carcinoma Patients With Synchronous and Metachronous Brain Metastases.
Parmar A; Soliman H; Sahgal A; Bjarnason GA
Clin Genitourin Cancer; 2020 Jun; 18(3):e224-e232. PubMed ID: 32139300
[TBL] [Abstract][Full Text] [Related]
7. Timing of brain metastases development in metastatic renal cell cancer patients treated with targeted therapies and survival outcomes: An Australian multicenter study.
Ha FJ; Spain L; Dowling A; Kwan EM; Pezaro C; Day D; Chia PL; Tran B; Pook D; Weickhardt AJ
Asia Pac J Clin Oncol; 2019 Oct; 15(5):e97-e102. PubMed ID: 30701671
[TBL] [Abstract][Full Text] [Related]
8. Multiple Pulmonary Resections for Synchronous and Metachronous Lung Cancer at Two Chinese Centers.
Kang X; Zhang C; Zhou H; Zhang J; Yan W; Zhong WZ; Chen KN
Ann Thorac Surg; 2020 Mar; 109(3):856-863. PubMed ID: 31765616
[TBL] [Abstract][Full Text] [Related]
9. Comparison Between Surgical Resection and Stereotactic Radiosurgery in Patients with a Single Brain Metastasis from Non-Small Cell Lung Cancer.
Bougie E; Masson-Côté L; Mathieu D
World Neurosurg; 2015 Jun; 83(6):900-6. PubMed ID: 25659803
[TBL] [Abstract][Full Text] [Related]
10. The results of modern surgical therapy for multiple primary lung cancers.
Adebonojo SA; Moritz DM; Danby CA
Chest; 1997 Sep; 112(3):693-701. PubMed ID: 9315801
[TBL] [Abstract][Full Text] [Related]
11. Metachronous Brain Metastasis in patients with EGFR-mutant NSCLC indicates a worse prognosis.
Ouyang W; Yu J; Zhou Y; Xu Y; Li J; Gong J; Zhang J; Xie C
J Cancer; 2020; 11(24):7283-7290. PubMed ID: 33193892
[No Abstract] [Full Text] [Related]
12. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease.
Heron DE; Komarnicky LT; Hyslop T; Schwartz GF; Mansfield CM
Cancer; 2000 Jun; 88(12):2739-50. PubMed ID: 10870056
[TBL] [Abstract][Full Text] [Related]
13. Prognosis of patients with non-small cell lung cancer with isolated brain metastases undergoing combined surgical treatment.
Getman V; Devyatko E; Dunkler D; Eckersberger F; End A; Klepetko W; Marta G; Mueller MR
Eur J Cardiothorac Surg; 2004 Jun; 25(6):1107-13. PubMed ID: 15145017
[TBL] [Abstract][Full Text] [Related]
14. [Impact of time of occurrence of liver metastases (synchronous vs. metachronous) on early postoperative outcome and long-term survival of colorectal cancer patients].
Bova R; Kamphues C; Neuhaus P; Puhl G
Zentralbl Chir; 2014 Apr; 139(2):220-5. PubMed ID: 23846535
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency ablation of T1 lung carcinoma: comparison of outcomes for first primary, metachronous, and synchronous lung tumors.
Ridge CA; Silk M; Petre EN; Erinjeri JP; Alago W; Downey RJ; Sofocleous CT; Thornton RH; Solomon SB
J Vasc Interv Radiol; 2014 Jul; 25(7):989-96. PubMed ID: 24703321
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological characteristics and prognosis of synchronous brain metastases from non-small cell lung cancer compared with metachronous brain metastases.
Li J; Zhang X; Wang Y; Jin Y; Song Y; Wang T
Front Oncol; 2024; 14():1400792. PubMed ID: 38841157
[TBL] [Abstract][Full Text] [Related]
17. Outcome and prognostic factors in single brain metastases from small-cell lung cancer.
Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hörner-Rieber J; König L; Kappes J; Thomas M; Unterberg A; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
Strahlenther Onkol; 2018 Feb; 194(2):98-106. PubMed ID: 29085978
[TBL] [Abstract][Full Text] [Related]
18. Surgical treatment of primary lung cancer with synchronous brain metastases.
Billing PS; Miller DL; Allen MS; Deschamps C; Trastek VF; Pairolero PC
J Thorac Cardiovasc Surg; 2001 Sep; 122(3):548-53. PubMed ID: 11547308
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis.
Tanvetyanon T; Robinson LA; Schell MJ; Strong VE; Kapoor R; Coit DG; Bepler G
J Clin Oncol; 2008 Mar; 26(7):1142-7. PubMed ID: 18309950
[TBL] [Abstract][Full Text] [Related]
20. Second primary lung cancer and relapse: treatment and follow-up.
Angeletti CA; Mussi A; Janni A; Lucchi M; Ribechini A; Chella A; Fontanini G
Eur J Cardiothorac Surg; 1995; 9(11):607-11. PubMed ID: 8751247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
